CompletedNot Applicable

the Effect of Abdominal Massage on the Gastric Residual Volume.

Pakistan34 participantsStarted 2023-11-01

Plain-language summary

The goals of this randomized controlled trial are: 1. To determine the mean gastric residual volume in ICU admitted adult patients before and after intervention. 2. To compare the gastric residual volume between the intervention and control group. Participants will be randomized in two groups (intervention and control group) Intervention group: The intervention period will be 3 days for intervention group. These patients will receive 20 minutes of abdominal massage twice a day, and the interval between two massages will be 2 hours. The outcome variable variable gastric residual volume will be measured every day, before the intervention and 1 hour after the second massage. the GRV will be measured in ml (via feeding syringe) and marked on checklist. Control group The control group will receive standard/usual care The abdominal massage technique will consist of five steps based on tensegrity principle

Who can participate

Age range

18 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients having NG tube (for check the GRV). * glasgow coma scale less than 7 (because usually these patients need gavage) * patients having age 18-60 years. Exclusion Criteria: * Patients receiving pro-kinetic medications (to avoid interfering with the massage effects) * Patients having abdominal radiotherapy during last 6 weeks. * Patients with abdominal aortic aneurysm and undergoing radiotherapy * Patients having abdominal surgery.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Gastric Residual Volume

Timeframe: before and after intervention ( 3 hours duration)

Trial details

NCT IDNCT06062381

SponsorUniversity of Health Sciences Lahore

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-01-10

View on ClinicalTrials.gov More Gastric Retention trials